Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

32 results for Pharmaceuticals
CLEAR ALL
Actylis
Antimicrobial, preservative, antioxidant and reducing excipient for injectable formulations.Benefits:
  • Maintains low level of endotoxins with bioburden limits (BET and MLT) controlled as a part of specifications
  • Metallic impurities controlled to suit the application
  • It is GMP and EXCiPACT certified
  • Complies with USP-…
Actylis
Excipient developed for pharmaceutical applications. It is used as pH modifier and buffering agent in injectable formulations. Benefits:
  • Complies with HP specifications
  • Helps to maintain low level of endotoxins and metallic impurities
Actylis
Buffering agent and pH modifier developed exclusively for use in injectable formulations.Benefits:
  • DMF Filed - CDE # F20200000141
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
Actylis
Solvent and co-solvent designed for injectable formulations. This excipient is used as a buffering agent and pH modifier. Benefits:
  • Highly pure, gives sweet taste
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with CDMF, USP, Ph Eur specification
Actylis
Solvent, buffering agent and pH modifier designed for injectable formulations. This excipient is also used as a co-solvent in pharmaceutical preparations. Benefits:
  • Highly pure syrupy liquid
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with USP, Ph. Eur and BP specification
Actylis
Solvent, buffering agent and pH modifier suitable for injectable formulations. This excipient also acts as a co-solvent in pharmaceutical preparations.Benefits:
  • Highly pure syrupy liquid
  • Complies with USP, Ph. Eur and BP specification
  • Helps to maintain low level of endotoxins and metallic impurities
Actylis
Excipient developed for pharmaceutical preparations. It is used as a buffering agent and pH modifier in injectable formulations. Benefits:
  • Colorless syrupy liquid
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with USP, Ph. Eur and BP specifications
Actylis
Preservative specially developed for injectable formulations, solid and semi-solid dosage forms.Benefits:
  • DMF Filed
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc) 
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent/ Co-solvent and chelating agent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Preservative and antimicrobial excipient for injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
Actylis
Preservative and antimicrobial excipient used in injectable formulations.Benefits:
  • Controlled metallic impurities
  • Maintains low level of endotoxins with the bioburden limits- BET/MLT
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Antioxidant and reducing agent used in injectable formulations. t is an excipient designed for solid and semi-solid dosage forms. Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient designed for solid and semi-solid dosage forms. Antioxidant and reducing agent developed for injectable formulations.Benefits:
  • DMF Filed - CDE # F20200000189
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)